Haematology Tutorial Flashcards

1
Q

What are local factors that cause oral candidiasis?

A

Antibiotic use, dentures, local corticosteroid use, xerostomia (drug induced or radiotherapy induced).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are general factors that cause oral candidiasis?

A

Drugs, extremes of age, endocrine (Cushings and diabetes mellitus), immunodeficiency (hereditary or acquired), iron deficiency and smoking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are risk factors for periodontitis?

A

Smoking, alcohol, poor oral hygiene, diabetes, dry mouth, poor diet and nutrition etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is atrial fibrilation?

A

Atrial fibrillation is a heart condition that causes an irregular and often abnormally fast heart rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What complications can occur as a result of atrial fibrilation?

A

Can result in complications such as: pulmonary embolism (PE); deep vein thrombosis (DVT); cerebro- vascular accident (CVA/stroke), and myocardial infarction (heart attack/MI).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can diabetes be related to oral health?

A
  • Risk of hypoglycaemic episode – medical emergency
  • Periodontal Disease
  • Delayed healing
  • Salivary gland dysfunction
  • Oral dysesthesia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is hypertension a risk factor of?

A

Heart disease, Heart attacks, Strokes, Heart failure, Peripheral arterial disease, Aortic aneurysms, Kidney disease, Vascular dementia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is warfarin?

A

It is a vitamin K antagonist. Warfarin blocks the liver from using vitamin K to make clotting factors. This thins your blood, so it takes longer to clot.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is NOAC?

A

The novel oral anticoagulants (NOACs) are a new class of anticoagulant drug. They can be used in the prevention of stroke for people with non-valvular AF, which is when AF is not associated with a problem in a heart valve. INR does not need checked with these drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is simvastatin for?

A

HMG CoA reductase inhibitors and are used to treat hypercholesterolaemia. This group of drugs may have interactions with other medications you can prescribe as a dental practitioner.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is furosemide used for?

A

This medication is one of the loop diuretics. It is used in combination with other hypertensive medications to control resistant hypertension.
The loop diuretics can exacerbate diabetes. However, there is less risk of hyperglycaemia when compared to the use of the thiazide diuretics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is carvediol used for?

A

This a beta blocker. When considered in this context for its use in the management of hypertension it gives us an indication that this gentleman is not receiving a first line treatment. This should encourage us to consider the relevance of hypertension to our delivery of dental care.
Individuals who are medicated with non-selective beta blockers have a heightened sensitivity to the effects of vasopressors present in local anaesthetics. This can result in an increase in vascular resistance with a subsequent increase in blood pressure. There are reports in the medical literature of MI and stroke occurring as a consequence. This risk is small in the practice of dentistry and can be prevented with appropriate drug selection and local anaesthetic technique.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What appointment time is the best for a diabetic individual?

A

We should consider timing appointments to ensure his blood glucose levels are appropriate for treatment and do not coincide with time of peak insulin activity as this presents the greatest risk for hypoglycaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is metformin used for?

A

Metformin hydrochloride has an anti-hyperglycaemic effect.
Metformin hydrochloride is recommended as the first choice for initial treatment for all patients with diabetes, due to its positive effect on weight loss, reduced risk of hypoglycaemic events and the additional long-term cardiovascular benefits associated with its use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is hypertension needed to be controlled within dentistry?

A

It is important we firstly establish the stage of this gentleman’s hypertension. A hypertensive crisis (>180/110) is a medical emergency. Uncontrolled hypertension may need to be controlled before the delivery of dental treatment. If dental anxiety is a trigger for significant and dangerous increases in blood pressure it may be valuable to consider the role of sedation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What diabetic test measures the patients last 3 months of sugars?

A

HBIAC test.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the relevance of warfarin in dentistry?

A

Prior to providing any dental treatment it would be valuable to understand what this gentleman’s bleeding risk is.
This can be established through a special investigation. The INR is the test of relevance to dental practitioner. This will allow us to assess this gentleman’s bleeding risk and warfarin control.
It is possible to provide some treatment for Mr Fraser today. You could provide him with the initial preventative messages that are essential to the long-term maintenance of oral health.
Depending on how much information is available to you today will determine whether you are able to proceed with any operative care.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How can dentists manage oral candidiasis?

A

Candida exist in a biofilm. Therefore, initially we should observe the principles of biofilm management and consider mechanical disruption. Additionally, it should be noted that there is an increase in the resistance profile of candida species to drug therapies.
We should encourage the gentleman to:
1. Use a toothbrush or some gauze to clean the palate. This could be supplemented with the short- term use of Corsodyl mouthwash or gel
2. Denture hygiene should be observed
3. The patient should be encouraged to remove the denture at night
4. Candida species can penetrate the acrylic of dentures. Therefore, appropriate cleaning or even potentially a new denture may be required
5. It should be reinforced that underlying causes should be consider and investigated
If first line management fails, the use of medications should be considered. Whenever considering the prescribing of medications we must evaluate the risk of interactions and consider the patients systemic health.
It would be appropriate to start with a local agent in the management of pseudomembranous candidosis.
a) Miconazole – This drug is contraindicated in patients taking warfarin as it potentiates the anticoagulant effect
It is also contraindicated for patient prescribed a statin as there is a possible increased risk of myopathy
b) Nystatin
This medication is safe to use in patients prescribed warfarin
The use of systemic agents in the management of oral candidiasis should be considered as a final option for the majority or individuals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is an INR?

A

An INR is a type of blood test and it is particularly useful for monitoring individuals taking the medication warfarin.
The INR is a ratio. It is calculated by taking the prothrombin time (PT – time for plasma to clot) of the patient and dividing it by a reference PT plasma value which has been corrected for the thromboplastin used in the test.
INR = PT / Reference PT Plasma
The INR value of a normal healthy individual should be 1.
For patient prescribed warfarin, there are target ranges in which the patient’s INR should sit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How close to the appointment do you want an INR text to be done if the patient is taking warfarin?

A

We have not previously met this individual. If we had access to his INR results we could assess the level of control of his medication and assess the risk of undertaking any procedures. We can access this information through digital medical records or in a more traditional setting in a yellow book which the patient may carry.
If we take everything into account about this gentleman including his poor control of diabetes, his multiple risk factors for a number of diseases it would seem sensible to obtain an INR at least 24 hours prior to providing any care for him.
It is always sensible to fully evaluate a patient prior to undertaking any operative care. Whilst guidelines classify risk and discuss safe procedures, it would always be good practice to fully assess and evaluate each patient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What INR does a warfarin patent need in order to get a tooth taken out?

A

The INR value today is 4. The SDCEP guidelines state that the INR level should be less than 4 for a tooth to be removed safely.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does a varitation in INR value mean?

A

When we assess they level of variability displayed in Mr Fraser’s INR, we can see that the values obtained change significantly. This variance tells us that Mr Fraser’s control of his warfarin use is not as good as it could be. Therefore, he potentially presents a higher risk of complications. This is another reason to ensure that you have an INR undertaken within 24 hours of providing an extraction procedure that may cause post-operative bleeding. Changes in lifestyle, stress, what you drink, Medications (Antibiotics).

23
Q

How would you limit the risk of bleeding in patients?

A

To limit the risk of bleeding the following should be considered:
1. Consider if the drug regime is short or long term. If it is short term only can the treatment be delayed
(Mr Fraser’s warfarin use is lifelong)
2. Plan the treatment for early in the day or week to allow time for the management of any complications
3. Undertake an atraumatic technique to dental extractions and surgery 4. Use appropriate measures to establish haemostasis
5. Consider the staging of treatment by limiting the initial area of surgery and evaluating haemostasis before proceeding, utilise haemostatic adjuvants and post-operative monitoring
6. Advise on the use of paracetamol analgesia unless contraindicated instead of NSAIDs 7. Provide full written instructions and emergency contact details.

24
Q

If a patient does not stop bleeding what are alternative measures that you can take?

A
  • Sockets should be gently packed with an absorbable haemostatic dressing: oxidised cellulose (Surgicel®), collagen sponge (Haemocollagen®) or resorbable gelatin sponge (Spongostan®)
  • Sutures. Resorbable (catgut or synthetic (polyglactin, Vicryl®)) or non-resorbable (silk, polyamide,
    polypropylene) sutures. Resorbable sutures are preferable as they attract less plaque.47 If non-
    resorbable sutures are used they should be removed after 4-7 days.
  • Following closure, pressure should be applied to the socket(s) by using a gauze pad that the patient
    bites down on for 20 minutes.
  • Atraumatic technique
  • The use of tranexamic acid mouthwash, which acts as a local antifibrinolytic agent, is not routinely
    recommended in primary care.
25
Q

What are post op instructions?

A

Patients should be given clear instructions (preferably in writing) on the management of the clot in the postoperative period and advised:
• to look after the initial clot by resting while the local anesthetic wears off and the clot fully forms (2-3 hours),
• to avoid rinsing the mouth for 24 hours,
• not to suck hard or disturb the socket with the tongue or any foreign object,
• to avoid hot liquids and hard foods for the rest of the day,
• to avoid chewing on the affected side until it is clear that a stable clot has formed. Care should then be taken to
avoid dislodging the clot,
• if bleeding continues or restarts to apply pressure over the socket using a folded clean handkerchief or gauze
pad. Place the pad over the socket and bite down firmly for 20 minutes. If bleeding does not stop, the dentist
should be contacted; repacking and resuturing of the socket may be required.
• Who to contact if they have excessive or prolonged postoperative bleeding. The surgery and out of hours/on
call dentist’s name/number should be provided. There should be a facility for the patient to be reviewed and treated immediately by a dentist if a bleeding problem occurs. If it is not possible for the patient to be seen immediately by a dentist then the patient should be referred to their local accident and emergency department.
• On pain control the preferential use of paracetamol unless contraindicated.

26
Q

What is apixaban?

A

Apixaban
Eliquis
Action- Factor Xa inhibitor
Prevention of stroke and systemic embolism in people with nonvalvular atrial fibrillation
Treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism
Reversal- Activated charcoal may prevent absorption if administered with 1 - 2 hours of ingestion
Current trial: “Andexanet alfa”
Blood test- Chromogenic anti-Xa assays.

27
Q

What is dabigatran?

A

Dabigatran
Pradaxa
Action- Direct Thrombin Inhibitor
Prevention of stroke and systemic embolism in atrial fibrillation
Prevention of venous thromboembolism after hip or knee replacement surgery in adults

Reversal-Idarucizumab
Blood test- diluted thrombin time (dTT), Ecarin- based assays such as ecarin chromogenic assay (ECA)

28
Q

Edoxiban?

A

Edoxiban
Lixiana
Mechanism- Factor Xa inhibitor
Prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation
Prevention of deep vein thrombosis and pulmonary embolism

Reversal- Activated charcoal may prevent absorption if administered with 1 - 2 hours of ingestion
Current trial: “Ciraparantag”

Blood test- chromogenic anti-Xa assays.

29
Q

Rivaroxiban?

A

Rivoroxiban
Xarelto
Mechanism- Factor Xa inhibitor
Prevention of stroke and systemic embolism in people with atrial fibrillation
Treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
Prevention of venous thromboembolism after total hip or total knee replacement in adults
Prevention of adverse outcomes after acute management of acute coronary syndrome
Reversal- Activated charcoal may prevent absorption if administered with 1 - 2 hours of ingestion
Current trial: “Andexanet alfa”
Blood test- Chromogenic anti-Xa assays.

30
Q

What are weaknesses of NOACS?

A
  • Do not exist standardized test for monitoring of NOACs, when it is necessary for monitoring of these drugs, e.g., in hepatic and renal disease
  • Sometimes rapid offset and short half-life may be considered as disadvantages
  • Currently lack of antidote
  • High cost
  • Not enough experience.
31
Q

What are the benefits of NOAC drugs?

A
  • Predictable pharmacokinetics and pharmacodynamics
  • Rapid onset and offset Short half-life
  • Low drug–drug and food interactions
  • No dietary restriction
  • In general, no need for laboratory monitoring, although in some cases it is required
  • Wide therapeutic window.
32
Q

If a patient has significant swelling on one knee and has a history of “bleeding into the joints”, what condition could this be?

A

You should have noted the significant swelling associated with the right knee. Given the context in which you are seeing this patient, a haemophilia and coagulation unit, such a presentation should start alarm bells ringing. It is important that this issue is managed swiftly as an emergency and should take priority over any dental treatment.
The swelling is likely to be a hemarthrosis. This is bleeding into a joint space and is associated with haemophilia.
Damage to the articular cartilage within the joint is a common consequence of repeated hemarthroses. Intraosseous haemorrhage may lead to bone resorption and the development of bone cysts.
This highlights the importance of full assessment of patient. We should evaluate each of patients from the minute they walk in through the door. There are many features of systemic disease which we can observe and will inform our medical risk assessment and ensure we manage patient in a safe and holistic way. Could suffer from haemophillia.

33
Q

What are the two types of haemophillia?

A

Haemophilia A – deficiency in Fact VIII, most common (85% of all cases)
Haemophilia B – deficiency in Factor IX

Both forms of haemophilia are x-linked recessive conditions and can only be differentiated through coagulation factor assays.
The severity of Haemophilia exists across a spectrum: Severe = < 1% Factor present
Moderate = 2-5% Factor present
Mild = 6-40% Factor present
This information should be obtained through a Haemophilia centre.

34
Q

What is DDAVP?

A

Desmopression. It is used to help stop bleeding in patients with Von Willebrand’s disease of haemophillia A. DDAVP causes the release of von willebrand’s antigen from the platelets and the cells that line the blood vessel where it is stored. This antigen carries factor V111.

35
Q

How does your treatment planning change with a haemophiliac patient?

A

Examinations and treatment which does not require manipulation of the mucosa are safe to deliver to patients with this condition.
In general, the delivery of supragingival restorations, crowns and bridges with the use of infiltration anaesthesia is safe to provide for people with haemophilia within the general dental practice setting.
However, for dental extractions, surgical procedures, subgingival scaling or anaesthesia requiring inferior alveolar nerve blocks of lingual infiltrations it is necessary for these patients to be seen at a dental clinic associated with a haemophilia centre. With these procedures there is an increased risk of bleeding which requiring medical prophylaxis and appropriate monitoring. Consideration should be given to the use of articaine infiltration and intraligamental injections to avoid IANBs.
For patient with mild haemophilia or Von Willebrand’s disease, the use of DDAVP is normally undertaken to provide dental procedures which present an increased risk of bleeding.
For patients with moderate and severe haemophilia it is likely factor replacement will be required

This affects treatment planning as we wish to reduce the number of times any patient has to be exposed to factor replacement as:
- Risk of blood borne infections if plasma derived factor is used although blood products are comprehensively screened (recombinant factor is genetically made and therefore all but negates the risk BBV transmission)
- Risk of local site infection
- Risk of inhibitors / antibodies developing
- Cost
Tranexamic acid, an antifibrinolytic agent may also be used in the management of this group of patients.

36
Q

Why should aspirin not be stopped pre-op?

A

It has a long half-life.
-7-10 days. It irreversibly binds to COX 1/2. You would have to stop it for days pre-op which puts the patient at risk of cardiovascular complications.

37
Q

What is post-op reactionary bleeding?

A

Bleeding 2-48 hours post-op.

38
Q

What is post-op secondary bleeding?

A

Bleeding 7-10 days post-op.

39
Q

What guidance is given for haemophiliac patients after a recent CV attack?

A

Delay non-emergency treatment for 6 months.

40
Q

What factors does warfarin inhibit?

A

Factors 2, 7, 9 and 10.

41
Q

What INR value allows for an extraction to go ahead?

A

under 4.

42
Q

When should INR be measured pre-op?

A

No more than 72 hours before for a well controlled individual (ideally 24 hours).

43
Q

What does an INR of 4 mean?

A

Blood takes 4x longer to clot than it usually should against a normal standardised ratio. INR measures prothrombin time
(the time blood takes to clot) against what is normal.

44
Q

What drugs should be avoided in patients taking warfarin?

A

Statins, NSAIDs, some antibiotics and azole antifungals.

45
Q

What is the mechanism of action of NOACs?

A

Inhibits factors 10 and 10a.

46
Q

What is the management of patients taking NOACs and low-risk bleeding procedures?

A

Treat without interruption.

47
Q

What is the management for patients taking NOACs and high risk bleeding procedures?

A

Delay or miss dose according to SDCEP guidelines.

48
Q

Name examples of low risk bleeding procedures.

A

Simple extractions, supra gingival scaling, incision and drainage or intra oral swellings.

49
Q

Name examples of high risk bleeding procedures.

A

Complex extractions, biopses, flap raising procedures etc.

50
Q

What are examples of antiplatelet medications?

A

Aspirin, NSAIDs, clopidogrel, dipyramidole.

51
Q

How should a patient be managed on aspirin only?

A

Treat without interruption.

52
Q

How should a patient be managed on dual therapy anti-platelets?

A

Treat without interruption.

53
Q

What cautions should be considering with NSAIDs?

A
  • Other medications that increase bleeding risk
  • Asthmatics
  • Peptic ulcers and those at risk of GI bleeds.